Invention Grant
- Patent Title: Erythropoietin variants
-
Application No.: US12334995Application Date: 2008-12-15
-
Publication No.: US09988427B2Publication Date: 2018-06-05
- Inventor: Andreas Meisel , Josef Priller , Christel Bonnas , Ulrich Dirnagl
- Applicant: Andreas Meisel , Josef Priller , Christel Bonnas , Ulrich Dirnagl
- Applicant Address: DE Berlin
- Assignee: CHARITE UNIVERSITAETSMEDIZEN-BERLIN
- Current Assignee: CHARITE UNIVERSITAETSMEDIZEN-BERLIN
- Current Assignee Address: DE Berlin
- Agency: Acuity Law Group, PC
- Agent Michael A. Whittaker
- Priority: EP05010473 20050513
- Main IPC: C07K14/505
- IPC: C07K14/505 ; A61K38/18 ; A61K38/00
Abstract:
The present invention relates to novel endogenous variants of erythropoietin (EPO) and their use for treatment or prevention of a condition associated with tissue damage due to cell death (apoptosis, necrosis) and inflammation, in particular for neuroprotection, e.g. treatment of acute (for example stroke) and chronic disease (for example ALS) of the nervous system.
Public/Granted literature
- US20110008363A1 ERYTHROPOIETIN VARIANTS Public/Granted day:2011-01-13
Information query
